When you have a chronic disease like Crohn's, it is important to talk to your doctor about treatment goals. These goals may include symptom control and long-term remission (periods of few or no symptoms). REMICADE® can provide symptom relief and long-lasting symptom control to help keep your Crohn’s in remission.

In a 1-year clinical study

4 OUT OF 10

patients achieved remission, or a period of few to no symptoms, with REMICADE® compared with 2.5 out of 10 patients not given REMICADE®.


At Week 2, nearly 6 out of 10 patients achieved control of their Crohn’s symptoms.

More patients experienced remission through 1 year with REMICADE® compared with those not given REMICADE®.

Over 400,000 people with moderately to severely active Crohn's have been prescribed REMICADE® in the United States.


of patients (36 out of 40) regained control of their Crohn's symptoms with an increased dose of REMICADE® after losing control with 5 mg/kg.

If you lose response to REMICADE® at 5 mg/kg, your doctor may consider increasing your dose to 10 mg/kg. If you don't respond by Week 14, your doctor should discuss discontinuing REMICADE® and trying another treatment.

Download additional resources for more information about treatment with REMICADE®.

Ask your doctor how REMICADE® can help control your Crohn’s symptoms.

REMICADE® isn’t right for everyone, and individual results may vary. Talk with your doctor to decide if REMICADE® may be right for you.